- Case report
- Open Access
Delayed lumbar plexus palsy due to giant psoas hematoma associated with vertebral compression fracture and direct oral anticoagulants: a case report
BMC Musculoskeletal Disorders volume 22, Article number: 377 (2021)
Osteoporotic vertebral compression fractures (VCFs) are commonly observed in elderly people and can be treated by conservatively with minimal risk of complications in most cases. However, utilization of direct oral anticoagulants (DOACs) increases the risks of secondary hematoma even after insignificant trauma. The use of DOACs increased over the past decade because of their approval and recommendation for both stroke prevention in non-valvular atrial fibrillation and treatment of venous thromboembolism. It is well known that DOACs are safer anticoagulants than warfarin in terms of major and nonmajor bleeding; however, we noted an increase in the number of bleeding events associated with DOACs that required medical intervention. This report describes the first case of delayed lumbar plexus palsy due to DOAC-associated psoas hematoma after VCF to draw attention to potential risk of severe complication associated with this type of common and stable trauma.
An 83-year-old man presented with his left inguinal pain and inability to ambulate after falling from standing position and was prescribed DOACs for chronic atrial fibrillation. Computed tomography angiography revealed a giant psoas hematoma arising from the ruptured segmental artery running around fractured L4 vertebra. Because of motor weakness of his lower limbs and expansion of psoas hematoma revealed by contrast computed tomography on day 8 of his hospital stay, angiography aimed for transcatheter arterial embolization was tried, but could not demonstrate any major active extravasation; therefore spontaneous hemostasis was expected with heparin replacement. On day 23 of his stay, hematoma turned to decrease, but dysarthria and motor weakness due to left side cerebral infarction occurred. His pain improved and bone healing was achieved about 2 months later from his admission, however the paralysis of the left lower limb and aftereffects of cerebral infarction remained after 1 year.
In patients using DOACs with multiple risk factors, close attention must be taken in vertebral injury even if the fracture itself is a stable-type such as VCF, because segmental artery injury may cause massive psoas hematoma followed by lumbar plexus palsy and other complications.
Osteoporotic vertebral compression fractures (VCFs) are commonly observed in elderly people and are treated successfully by conservative therapy . Recently, the long-term prognosis for lasting pain, disability, activities of daily living, and quality of life after VCFs has been reported ; however, acute, severe complications of this injury are rare and not well known.
The use of direct oral anticoagulants (DOACs) for both stroke prevention in non-valvular atrial fibrillation and treatment of venous thromboembolism increased over the past decade because of their approval and recommendation . Although DOACs are also well known as safer anticoagulants as compared with warfarin in terms of major and nonmajor bleeding [4, 5], an increase in the number of bleeding events associated with DOACs that require medical intervention occurred [6, 7]. However, to our knowledge, currently, no reports exist on DOAC-related giant psoas hematoma after stable-type spinal injury.
To the best of our knowledge, this report describes the first case of lumbar plexus palsy attributed to DOAC-related secondary psoas hematoma after osteoporotic VCF. This case draws attention to the potential risk of severe complication associated with this type of common and stable trauma.
An 83-year-old man presented to our hospital with left inguinal pain, slight low-back pain, and the inability to ambulate because of pain after falling from a standing position without any neurologic deficits. He presented with a medical history of chronic atrial fibrillation, carotid artery stenosis, arteriosclerosis obliterans of the lower extremities, alcoholic liver disease, and diabetes mellitus. For the treatment of atrial fibrillation, he was using the DOAC edoxaban, which is a selective, reversible, and competitive inhibitor of human factor Xa.
Radiography showed no evidence of hip fracture but revealed a thickening of left psoas major muscle, and magnetic resonance imaging (MRI) showed stable-type VCF of the fourth lumbar vertebra (Fig. 1). Moreover, fast STIR MRI revealed a 53- × 54- × 142-mm intramuscular hematoma in the psoas major muscle, which expanded to the iliac muscle and around the hip joint (Fig. 2). Computed tomography angiography showed that the hematoma arose from the ruptured segmental artery running around the fractured vertebra (Fig. 3). Blood tests showed platelets of 149,000/mm3 (normal, 140,000–400,000), activated partial thromboplastin time (APTT) of 30.1 s (normal, 26–40 sections), and slightly prolonged international normalized ratio of prothrombin time of 1.25 (normal, 0.90–1.10). Creatinine was 1.22 mg/dL (normal, 0.5–1.0 mg/dL), with a creatinine clearance of 44.8 mL/min.
Based on the analysis of the blood coagulation system, we estimated that extravasation from the segmental artery was encouraged not by depletion of coagulation factors due to liver disorder but by DOAC usage, which does not affect APTT. Interrupting the anticoagulant therapy was considered to pose a risk of stroke because the patient exhibited a CHADS2 score (defined as congestive heart failure, hypertension, age ≥ 75 years, type 2 diabetes mellitus, previous stroke [doubled]) of 3 points, and his CHA2DS2-VASc (defined as congestive heart failure, hypertension, age ≥ 75 years, type 2 diabetes mellitus, previous stroke [doubled], vascular disease, age 65–74 years, sex category) score was 5 points. Conversely, continuation of edoxaban makes decreasing hematoma expansion difficult. Therefore, we chose to treat the patient with heparin replacement with a lower therapeutic range starting the day after admission and expected spontaneous hemostasis.
On day 8 of the patient’s hospital stay, neurologic examination revealed hypoesthesia and motor weakness of the left lower limb, evaluated as 13 of 25 points of the American Spinal Cord Injury Association (ASIA) motor score. Enhanced computed tomography showed that contrast die leaked into the hematoma from the injured segmental artery, and the psoas major muscle was tense due to a massively expanded hematoma (Fig. 4). Vascular surgery was consulted, and an angiography aimed for transcatheter arterial embolization (TAE) was performed but did not demonstrate any active extravasation; thus, TAE was abandoned. Percutaneous or surgical drainage was rejected because of the increased risk of bleeding complications and expected potential for spontaneous reduction, based on the findings of TAE. The hematoma began to decrease 1 week later.
On day 23 of his stay, the patient experienced dysarthria and motor weakness of the right upper limb, which was evaluated as 12 points of the ASIA motor score without any sensory disturbance. A brain MRI revealed cerebral infarction on the left cortex of the frontal lobe and radiate crown (Fig. 5), and the neurosurgeon selected conservative treatment rather than thrombolytic therapy. The patient’s low-back pain and inguinal pain disappeared and bone healing was achieved; furthermore, the psoas hematoma vanished approximately 2 months after the patient’s hospital admission (Fig. 6). However, the patient experienced persistent motor weakness of the left lower limb and right upper limb as well as dysarthria, with no neurologic improvement observed at 1-year follow-up.
Discussion and conclusions
To the best of our knowledge, this is the first report of delayed lumbar plexus palsy with DOAC-related massive psoas hematoma after osteoporotic VCF associated with the occurrence of segmental artery injury. Several reports revealed that spontaneous psoas hematoma is an infrequent complication of anticoagulant therapy [8,9,10,11,12,13]. In their retrospective multicentric study, Llitjos et al.  found that the occurrence of psoas hematoma was 3.01 cases/1000 admissions, and the mortality rate was 30%. Also, they revealed that 72% of the cases were related to anticoagulation therapy, including warfarin, unfractionated heparin, or low-molecular-weight heparin, except for DOACs. Ardebol et al.  reported the first case of spontaneous hematoma of the sartorius muscle secondary to rivaroxaban therapy; thus, DOAC-related muscular hematoma is rare. Indeed, it is much rarer for massive psoas hematoma to lead to lumber plexus palsy.
The frequency of major or clinically relevant nonmajor bleeding events related to edoxaban was reported to range from 3.8 to 19.2% [15,16,17,18,19]. Studies indicated that the risk factors of DOAC-related bleeding events include heavy alcohol use, uncontrolled hypertension, increasing age, heart failure, vascular disease, antiplatelet use, chronic renal failure, and diabetes mellitus [17, 20]. In our case, the patient’s age and comorbidities, including excess alcohol use, carotid artery stenosis, arteriosclerosis obliterans, and diabetes mellitus, possibly increased the risk of DOAC-related hematoma.
Lumbar segmental artery injury is usually observed in unstable injuries such as fracture dislocation [21, 22] or fracture of a patient with diffuse idiopathic skeletal hyperostosis . TAE can be the treatment of choice for this arterial injury [21,22,23,24,25,26]; however, percutaneous or surgical drainage should be carefully considered because no reversal for DOAC exists, except for dabigatran, and maintaining the congealing fibrinogenolytic system is difficult . In addition, emergency stabilization is effective for the prevention of secondary bleeding in cases of unstable vertebral injury .
Thus, in patients using DOACs with multiple risk factors, great care should be taken regarding vertebral injury, even if the fracture itself is a stable-type such as VCF, because segmental artery injury may result in massive psoas hematoma followed by lumbar plexus palsy and other complications.
Availability of data and materials
Activated partial thromboplastin time
American Spinal Cord Injury Association
Direct oral anticoagulants
Magnetic resonance imaging
Transcatheter arterial embolization
Vertebral compression fractures
Longo UG, Loppini M, Denaro L, Maffulli N, Denaro V. Conservative management of patients with an osteoporotic vertebral fracture: a review of the literature. J Bone Joint Surg Br. 2012;94:152–7.
Suzuki N, Ogikubo O, Hansson T. The prognosis for pain, disability, activities of daily living and quality of life after an acute osteoporotic vertebral body fracture: its relation to fracture level, type of fracture and grade of fracture deformation. Eur Spine J. 2009;18:77–88.
Chaudhary R, Sharma T, Garg J, Sukhi A, Bliden K, Tantry U, et al. Direct oral anticoagulants: a review on the current role and scope of reversal agents. J Thromb Thrombolysis. 2020;49:271–86.
Almutairi AR, Zhou L, Gellad WF, Lee JK, Slack MK, Martin JR, et al. Effectiveness and safety of non-vitamin K antagonist oral anticoagulants for atrial fibrillation and venous thromboembolism: a systematic review and meta-analyses. Clin Ther. 2017;39:1456–78.e36.
Kakkos SK, Kirkilesis GI, Tsolakis IA. Editor's choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials. Eur J Vasc Endovasc Surg. 2014;48:565–75.
Dabi A, Koutrouvelis AP. Reversal strategies for intracranial hemorrhage related to direct oral anticoagulant medications. Crit Care Res Pract. 2018;2018:4907164.
Rawal A, Ardeshna D, Minhas S, Cave B, Ibeguogu U, Khouzam R. Current status of oral anticoagulant reversal strategies: a review. Ann Transl Med. 2019;7:411.
Fernandes C, Pereira P, Rodrigues M. Spontaneous iliopsoas muscle haematoma as a complication of anticoagulation in acute cerebral venous thrombosis: to stop or not to stop (the anticoagulation)? BMJ Case Rep. 2015;2015:bcr2014206410.
Ho KJ, Gawley SD, Young MR. Psoas haematoma and femoral neuropathy associated with enoxaparin therapy. Int J Clin Pract. 2003;57:553–4.
Kurdoglu M, Onan MA, Turp A, Kurdoglu Z. Spontaneous iliopsoas haematoma during heparin anticoagulation: cause of fetal loss. J Obstet Gynaecol J Inst Obstet Gynaecol. 2008;28:543–4.
Llitjos JF, Daviaud F, Grimaldi D, Legriel S, Georges JL, Guerot E, et al. Ilio-psoas hematoma in the intensive care unit: a multicentric study. Ann Intensive Care. 2016;6:8.
Marquardt G, Barduzal Angles S, Leheta F, Seifert V. Spontaneous haematoma of the iliac psoas muscle: a case report and review of the literature. Arch Orthop Trauma Surg. 2002;122:109–11.
Niakan E, Carbone JE, Adams M, Schroeder FM. Anticoagulants, iliopsoas hematoma and femoral nerve compression. Am Fam Phys. 1991;44:2100–2.
Ardebol J, Cahueque M, Sanchez C. Spontaneous rupture and hematoma of the sartorius muscle secondary to rivaroxaban therapy. J Surg Case Rep. 2020;2020:rjaa090.
Buller HR. Edoxaban versus warfarin for venous thromboembolism. N Engl J Med. 2014;370:80–1.
Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369:2093–104.
Takase T, Ikesue H, Nakagawa H, Kinoshita M, Muroi N, Kitai T, et al. Risk factors for major bleeding and clinically relevant non-major bleeding in Japanese patients treated with edoxaban. Biol Pharma Bull. 2020;43:458–62.
Weitz JI, Connolly SJ, Patel I, Salazar D, Rohatagi S, Mendell J, et al. Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation. Thromb Haemost. 2010;104:633–41.
Yamashita T, Koretsune Y, Yasaka M, Inoue H, Kawai Y, Yamaguchi T, et al. Randomized, multicenter, warfarin-controlled phase II study of edoxaban in Japanese patients with non-valvular atrial fibrillation. Circ J. 2012;76:1840–7.
Kirchhof P, Haas S, Amarenco P, Hess S, Lambelet M, van Eickels M, et al. Impact of modifiable bleeding risk factors on major bleeding in patients with atrial fibrillation anticoagulated with rivaroxaban. J Am Heart Assoc. 2020;9:e009530.
Domenicucci M, Ramieri A, Lenzi J, Fontana E, Martini S. Pseudo-aneurysm of a lumbar artery after flexion-distraction injury of the thoraco-lumbar spine and surgical realignment: rupture treated by endovascular embolization. Spine. 2008;33:E81–4.
Koakutsu T, Aizawa T, Yuzawa H, Itoi E, Kushimoto S. Lumbar artery injury from which the Adamkiewicz artery originated associated with lumbar spine injury: successfully treated by transcatheter arterial embolization. Eur Spine J. 2016;25:124–8.
Kawashima T, Tohma Y, Takaoka M, Sano R, Takahashi A, Ito T, et al. Abdominal compartment syndrome caused by a lumbar spinal fracture induced lumbar artery injury in a patient with diffuse idiopathic skeletal hyperostosis: a case report. J Jpn Assoc Surg. 2014;28:267–72.
Aoki M, Tokue H, Shibuya K, Murata M, Hagiwara S, Oshima K. Transcatheter arterial embolization of a lumbar artery injury with traumatic aortic dissection. Ann Vasc Surg. 2017;45:262.e11–4.
Basile A, Medina JG, Mundo E, Medina VG, Leal R. Transcatheter arterial embolization of concurrent spontaneous hematomas of the rectus sheath and psoas muscle in patients undergoing anticoagulation. Cardiovasc Intervent Radiol. 2004;27:659–62.
Sofocleous CT, Hinrichs CR, Hubbi B, Doddakashi S, Bahramipour P, Schubert J. Embolization of isolated lumbar artery injuries in trauma patients. Cardiovasc Intervent Radiol. 2005;28:730–5.
Okamoto K, Ichinose M, Hanaoka J. Traumatic hemothorax due to chance fracture requiring emergency surgical management: a report of two cases. SAGE Open Med Case Rep. 2018;6:2050313X18819617.
The author would like to thank Enago (www.enago.jp) for the English language review.
No financial support for this study was provided.
Ethics approval and consent to participate
Ethics approval and consent to participate were waived because this study is a case report.
Consent for publication
A written informed consent for the publication of patient information and images was obtained from the patient.
The authors report no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Ishii, C., Komatsu, M., Suda, K. et al. Delayed lumbar plexus palsy due to giant psoas hematoma associated with vertebral compression fracture and direct oral anticoagulants: a case report. BMC Musculoskelet Disord 22, 377 (2021). https://doi.org/10.1186/s12891-021-04267-9
- Spinal fractures
- Atrial fibrillation
- Vertebral artery
- Direct oral anticoagulants